SUMMARY
On April 21, 2022, the Centers for Disease Control and Prevention (CDC) published a health advisory alerting clinicians and public health authorities to a cluster of 9 children with hepatitis and adenovirus infection identified in Alabama1. CDC is investigating this association between pediatric hepatitis and adenovirus. The cases occurred between October 2021 and February 2022. A growing number of similar cases of pediatric hepatitis have been reported in Europe. As of April 29, 2022, there have been no reports of hepatitis and adenovirus infection among pediatric patients in the District of Columbia. CDC has issued recommendations for testing and reporting for pediatric cases of hepatitis of unknown etiology. Clinicians are instructed to report all such cases to DC Health to help local public health authorities and the CDC monitor occurrence as well as characterize factors associated with this illness. This health notice provides recommendations, reporting guidelines, and resources on hepatitis and adenovirus infection.